SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-204925
Filing Date
2009-10-07
Accepted
2009-10-07 15:50:17
Documents
4
Period of Report
2009-10-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16714
2 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 20741
3 AMENDMENT NO. 1 TO THE AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN dex101.htm EX-10.1 6704
4 AMENDED AND RESTATED DIRECTOR STOCK OPTION AND RESTRICTED STOCK AWARD PLAN dex102.htm EX-10.2 81541
  Complete submission text file 0001193125-09-204925.txt   127193
Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 091110141
SIC: 8060 Services-Hospitals